Naloxone market
Naloxone Market, By Strength (2.0 mg/ml, 1 mg/ml, 0.4 mg/ml, Others), By Route of Administration (Intranasal, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI1804
- 199 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Naloxone Market, By Strength
- Naloxone Market, By Route of Administration
- Naloxone Market, By Distribution Channel
- Naloxone Market, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
- Global Naloxone Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on the Demand and Supply of Naloxone
- Impact of COVID-19 on the Overall Healthcare Sector
- Global Naloxone Market, By Strength, 2019-2031 (USD MN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019-2031
- Segment Trends
- 2.0 mg/ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- 1mg/ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- 0.4 mg/ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Introduction
- Global Naloxone Market, By Route of Administration, 2019-2031 (USD MN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019-2031
- Segment Trends
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Intramuscular
- Subcutaneous
- Intravenous
- Introduction
- Global Naloxone Market, By Distribution Channel, 2019-2031 (USD MN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019-2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD MN)
- Introduction
- Global Naloxone Market, By Region, 2019-2031 (USD MN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
- North America
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country, 2019-2031 (USD MN)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country, 2019-2031 (USD MN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country, 2019-2031 (USD MN)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country, 2019-2031 (USD MN)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country, 2019-2031 (USD MN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Strength, 2019-2031 (USD MN)
- Market Size and Forecast, By Route of Administration, 2019-2031 (USD MN)
- Market Size and Forecast, By Distribution Channel, 2019-2031 (USD MN)
- Market Size and Forecast, By Country/Region, 2019-2031 (USD MN)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Viatris Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Opiant Pharmaceuticals
- Akorn Operating Company LLC
- Pfizer, Inc.
- Novartis AG
- Indivior Plc.
- Emergent BioSolutions Inc.
- Amphastar Pharmaceuticals, Inc.
- Kern Pharma, S.L.
- Hikma Pharmaceuticals PLC
- Mundipharma International Limited
- Kaleo, Inc.
- Pfizer Inc.
- Amneal Pharmaceuticals
- Viatris Inc.
- Somerset Pharma, LLC
- Orexo AB
- UCB Pharma
- Viatris Inc.
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 35 market data tables and 36 figures on “Naloxone Market” - Global Forecast to 2031.
Segmentation
Market Segmentation
- Strength:
- 2.0 mg/ml
- 1 mg/ml
- 0.4 mg/ml
- Others
- Route of Administration:
- Intranasal
- Injectable
- Intramuscular
- Subcutaneous
- Intravenous
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the naloxone market?
The CAGR of the naloxone market is projected to be 10.4% from 2024 to 2031.
What are the major factors driving the naloxone market growth?
Increasing dependency on drugs and opioids overdose and increasing initiatives by government and private organizations are the major factors driving the growth of the naloxone market.
What are the key factors hampering the growth of the naloxone market?
Lack of awareness about opioid overdose and stringent regulatory approval process are the major factors hampering the growth of the naloxone market.
Which is the leading strength in the naloxone market?
In terms of strength, 2.0 mg/ml is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the naloxone market?
EMERGENT, Indivior PLC, Akorn, Inc, Hikma Pharmaceuticals PLC, Viatris Inc., Sandoz, Teva Pharmaceuticals, Amphastar Pharmaceuticals, Inc., Kaleo, Inc., Pfizer Inc., Amneal Pharmaceuticals, Viatris Inc., Somerset Pharma, LLC, Orexo AB, and UCB Pharma are the major players.
Which region will lead the naloxone market?
North America is expected to lead the naloxone market.